Trastuzumab Emtansine

Category: Cancer



Trastuzumab Emtansine Overview

Trastuzumab emtansine[2][3] also known as ado-trastuzumab emtansine and sold under the trade name Kadcyla, is an antibody-drug conjugate consisting of the humanized monoclonal antibody trastuzumab (Herceptin) covalently linked to the cytotoxic agent DM1.[4][5][6][7] Trastuzumab alone stops growth of cancer cells by binding to the HER2 receptor, whereas trastuzumab emtansine undergoes receptor-media...

Read more Trastuzumab Emtansine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Trastuzumab_emtansine

Recent Trastuzumab Emtansine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Trastuzumab Emtansine
  • Injection: 100mg, 150mg, 420mg, 420mg/vial, 440mg, 600mg + 10000units
  • Vial: 100mg, 150mg, 160mg, 21mg/ml, 420mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Trastuzumab Emtansine or a similar ingredient: (12 results)